Kinetic analysis has documented that paeonol can act as a non-competitive repressor of tyrosinase and inhibit melanin synthesis in a dose-dependent manner in human melanoma cells (Lin et al., 2019), which provides a rationale for paeonol treatment of hyperpigmentation. Here, TYR is linked to melanoma.